Quinquenel A, Lepretre S, Dilhuydy MS, Bussot L, et al. Correction to: Real-world efficacy and safety outcomes of acalabrutinib in chronic lymphocytic leukemia: primary results of a French multicentre observational study (NAOS). Ann Hematol 2025 Oct 13. doi: 10.1007/s00277-025-06632.
PMID: 41081869